Clinical Trials Arena· GlobalData Healthcare·· 1 天前AI 评分26
ESMO26：Amgen 的 Imdelltra 在一线小细胞肺癌维持治疗中取得胜利
ESMO26: Amgen’s Imdelltra posts win in first-line SCLC maintenance setting
AI 导读
ESMO26 数据显示，Amgen 的 Imdelltra 在一线小细胞肺癌（SCLC）维持治疗中取得积极结果。该研究评估了这款药物在维持治疗场景下的表现，具体疗效数据尚未在摘要中披露。
正文 · 原文
Unlock FREE Access to Premium Content
Discover exclusive forecasts, analyst insights, and in-depth clinical trials industry analysis across drug development, clinical research, and trial innovation.
With a free Clinical Trials Arena profile, you can:
- Access exclusive analyst commentary and expert insights
- View premium forecasts and data-driven clinical trial intelligence
- Stay up to date with clinical trial news, regulatory updates, and industry trends
- Receive alerts when new premium content is published
Unlock free access
Already have an account? Login here
Powered by
来源：Clinical Trials Arena · clinicaltrialsarena.com